Emmanuelle Deslandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Emmanuelle Deslandes has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Sylvie Chevret
ECSTRRA Team, IRSL, INSERM UMR1342, Université Paris Cité, Paris, France
2 shared publications - Alexandre Demoule
Unité de Réanimation, Service de Pneumologie, Groupe Hospitalier Pitié Salpêtrière, Paris, France
1 shared publication - Elie Azoulay
Service de médecine intensive et réanimation, Hôpital Saint-Louis, Assistance Publique Des Hôpitaux de Paris, Paris, France
1 shared publication - Marine Chaize
Hôpitaux de Paris, Service de Réanimation Médicale, Hôpital Saint Louis, Paris, France
1 shared publication - Matthieu Schmidt
Sorbonne Université, INSERM, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition
1 shared publication - Nicolas Bele
Service de réanimation polyvalente, centre hospitalier de la Dracénie, route de Montferrat, 83007 Draguignan cedex, France
1 shared publication
Latest Publications
- Open Access
- 4 June 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (3) , 1-9
Intensive care unit admission in chronic obstructive pulmonary disease: patient information and the physician’s decision-making process
Introduction: ICU admission is required in more than 25% of patients with chronic obstructive pulmonary disease (COPD) at some time during the course of the disease. However, only limited information is available on how physicians communicate with COPD patients about ICU admission. Methods: COPD patients and relatives from 19 French ICUs were interviewed at ICU discharge about their knowledge of COPD. French pulmonologists self-reported their practices for informing and discussing intensive care treatment preferences with COPD patients. Finally, pulmonologists and ICU physicians reported barriers and facilitators for transfer of COPD patients to the ICU and to propose invasive mechanical ventilation. Results: Self-report questionnaires were filled in by 126 COPD patients and 102 relatives, and 173 pulmonologists and 135 ICU physicians were interviewed. For 41% (n = 39) of patients and 54% (n = 51) of relatives, ICU admission had never been expected prior to admission. One half of patients were not routinely informed by their pulmonologist about possible ICU admission at some time during the course of COPD. Moreover, treatment options (that is, non-invasive ventilation, intubation and mechanical ventilation or tracheotomy) were not explained to COPD patients during regular pulmonologist visits. Pulmonologists and ICU physician have different perceptions of the decision-making process pertaining to ICU admission and intubation. Conclusions: The information provided by pulmonologists to patients and families concerning the prognosis of COPD, the risks of ICU admission and specific care could be improved in order to deliver ICU care in accordance with the patient’s personal values and preferences. Given the discrepancies in the decision-making process between pulmonologists and intensivists, a more collaborative approach should probably be discussed.
- 4 June 2014
- Published by Springer Nature in Critical Care
- Vol. 18 (3) , 1-9
Open AccessIntensive care unit admission in chronic obstructive pulmonary disease: patient information and the physician’s decision-making process
Introduction: ICU admission is required in more than 25% of patients with chronic obstructive pulmonary disease (COPD) at some time during the course of the disease. However, only limited information is available on how physicians communicate with COPD patients about ICU admission. Methods: COPD patients and relatives from 19 French ICUs were interviewed at ICU discharge about their knowledge of COPD. French pulmonologists self-reported their practices for informing and discussing intensive care treatment preferences with COPD patients. Finally, pulmonologists and ICU physicians reported barriers and facilitators for transfer of COPD patients to the ICU and to propose invasive mechanical ventilation. Results: Self-report questionnaires were filled in by 126 COPD patients and 102 relatives, and 173 pulmonologists and 135 ICU physicians were interviewed. For 41% (n = 39) of patients and 54% (n = 51) of relatives, ICU admission had never been expected prior to admission. One half of patients were not routinely informed by their pulmonologist about possible ICU admission at some time during the course of COPD. Moreover, treatment options (that is, non-invasive ventilation, intubation and mechanical ventilation or tracheotomy) were not explained to COPD patients during regular pulmonologist visits. Pulmonologists and ICU physician have different perceptions of the decision-making process pertaining to ICU admission and intubation. Conclusions: The information provided by pulmonologists to patients and families concerning the prognosis of COPD, the risks of ICU admission and specific care could be improved in order to deliver ICU care in accordance with the patient’s personal values and preferences. Given the discrepancies in the decision-making process between pulmonologists and intensivists, a more collaborative approach should probably be discussed.
- Open Access
- 29 July 2010
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 10 (1) , 69
Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data
Joint modeling of longitudinal and survival data has been increasingly considered in clinical trials, notably in cancer and AIDS. In critically ill patients admitted to an intensive care unit (ICU), such models also appear to be of interest in the investigation of the effect of treatment on severity scores due to the likely association between the longitudinal score and the dropout process, either caused by deaths or live discharges from the ICU. However, in this competing risk setting, only cause-specific hazard sub-models for the multiple failure types data have been used.
- 29 July 2010
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 10 (1) , 69
Open AccessJoint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data
Joint modeling of longitudinal and survival data has been increasingly considered in clinical trials, notably in cancer and AIDS. In critically ill patients admitted to an intensive care unit (ICU), such models also appear to be of interest in the investigation of the effect of treatment on severity scores due to the likely association between the longitudinal score and the dropout process, either caused by deaths or live discharges from the ICU. However, in this competing risk setting, only cause-specific hazard sub-models for the multiple failure types data have been used.
- 3 December 2007
- Published by Wiley in Statistics in Medicine
- Vol. 26 (30) , 5411-5421
Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: Application to clinical trial data on chronic lymphocytic leukaemia
In clinical research, we are often interested in assessing how a biomarker changes with time, and whether it could be used as a surrogate marker when evaluating the efficacy of a new drug. However, when the longitudinal marker is correlated with survival, linear mixed models for longitudinal data may be inappropriate. By contrast, it may be possible to recover information from the so‐called informative censoring by modelling both the longitudinal information and the survival process. The objective of this work is to jointly model longitudinal and survival data to assess surrogacy. Two competitive modelling strategies were used, either a multistate model summarizing the course of longitudinal data and occurrence of disease progression or death, or a joint longitudinal‐survival model. We present both analyses based on a case study from two randomized clinical trials that enrolled patients with stage A chronic lymphocytic leukaemia (CLL) in order to obtain further insights into these different approaches. Copyright © 2007 John Wiley & Sons, Ltd.
- 3 December 2007
- Published by Wiley in Statistics in Medicine
- Vol. 26 (30) , 5411-5421
Assessing surrogacy from the joint modelling of multivariate longitudinal data and survival: Application to clinical trial data on chronic lymphocytic leukaemia
In clinical research, we are often interested in assessing how a biomarker changes with time, and whether it could be used as a surrogate marker when evaluating the efficacy of a new drug. However, when the longitudinal marker is correlated with survival, linear mixed models for longitudinal data may be inappropriate. By contrast, it may be possible to recover information from the so‐called informative censoring by modelling both the longitudinal information and the survival process. The objective of this work is to jointly model longitudinal and survival data to assess surrogacy. Two competitive modelling strategies were used, either a multistate model summarizing the course of longitudinal data and occurrence of disease progression or death, or a joint longitudinal‐survival model. We present both analyses based on a case study from two randomized clinical trials that enrolled patients with stage A chronic lymphocytic leukaemia (CLL) in order to obtain further insights into these different approaches. Copyright © 2007 John Wiley & Sons, Ltd.